Register entry

Siegfried Barbera, SL

Data as of · How to read this entry

Registered sites
0
Active NDC listings
12
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

12

12 active NDC listings: 12 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 12.

Dosage formNDCs
tablet, film coated9
capsule2
tablet1
RouteNDCs
Labeller name on the listingNDCs
siegfried barbera, sl12
Catalogue

Marketed products

12
BrandGeneric nameForm / routeNDC
-Amlodipine, valsartan and hydrochlorothiazidetablet, film coated81719-010DRUG FOR FURTHER PROCESSING
-Amlodipine, valsartan and hydrochlorothiazidetablet, film coated81719-011DRUG FOR FURTHER PROCESSING
-Amlodipine, valsartan and hydrochlorothiazidetablet, film coated81719-012DRUG FOR FURTHER PROCESSING
-Amlodipine, valsartan and hydrochlorothiazidetablet, film coated81719-013DRUG FOR FURTHER PROCESSING
-Amlodipine, valsartan and hydrochlorothiazidetablet, film coated81719-014DRUG FOR FURTHER PROCESSING
-Dabrafenib mesylatecapsule81719-015DRUG FOR FURTHER PROCESSING
-Dabrafenib mesylatecapsule81719-016DRUG FOR FURTHER PROCESSING
-Eltrombopag olaminetablet, film coated81719-004DRUG FOR FURTHER PROCESSING
-Eltrombopag olaminetablet, film coated81719-005DRUG FOR FURTHER PROCESSING
-Eltrombopag olaminetablet, film coated81719-006DRUG FOR FURTHER PROCESSING
-Eltrombopag olaminetablet, film coated81719-007DRUG FOR FURTHER PROCESSING
-Pazopanib hydrochloridetablet81719-017DRUG FOR FURTHER PROCESSING
Enquiry

Common questions

Is Siegfried Barbera, SL FDA approved?
Siegfried Barbera, SL holds no registered establishment of its own; 12 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Siegfried Barbera, SL make?
12 products are listed under Siegfried Barbera, SL in the openFDA NDC Directory, most often as tablet, film coated; capsule; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.